More Evidence That ACAT Is the Wrong Target for Lipid Lowering; ACAT Drug Does Not Seem to Work, Academic Medical Center Study

MedPage Today -- AMSTERDAM, March 17 -- Analysis of data from an aborted trial of a failed investigational drug provided still more evidence that attempting to control cholesterol by inhibiting an enzyme involved in its transport may be a bad idea.